Emerald Advisers, LLC Adamas Pharmaceuticals, Inc. Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
N/A
-642,226 Closed
0 $0
Q3 2020

Oct 28, 2020
SELL
N/A
-26,816 Reduced 4.01%
642,226 $2.65 Million
Q2 2020

Jul 28, 2020
BUY
N/A
37,595 Added 5.95%
669,042 $1.71 Million
Q1 2020

Apr 30, 2020
BUY
N/A
2,323 Added 0.37%
631,447 $1.83 Million
Q4 2019

Jan 29, 2020
SELL
N/A
-9,970 Reduced 1.56%
629,124 $2.38 Million
Q3 2019

Oct 31, 2019
SELL
N/A
-61,082 Reduced 8.72%
639,094 $3.27 Million
Q2 2019

Jul 31, 2019
BUY
N/A
73,929 Added 11.81%
700,176 $4.34 Million
Q1 2019

May 01, 2019
SELL
N/A
-24,102 Reduced 3.71%
626,247 $4.45 Million
Q4 2018

Jan 30, 2019
SELL
N/A
-12,195 Reduced 1.84%
650,349 $5.55 Million
Q3 2018

Oct 31, 2018
BUY
N/A
22,610 Added 3.53%
662,544 $13.3 Million
Q2 2018

Jul 31, 2018
BUY
N/A
13,821 Added 2.21%
639,934 $16.5 Million
Q1 2018

Apr 26, 2018
BUY
N/A
83,216 Added 15.33%
626,113 $15 Million
Q4 2017

Feb 05, 2018
BUY
N/A
14,830 Added 2.81%
542,897 $18.4 Million
Q3 2017

Oct 30, 2017
BUY
N/A
528,067
528,067 $11.2 Million

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email